Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor in stroke and brain injury.

P J Lindsberg1, J M Hallenbeck, G Feuerstein

  • 1Department of Neurology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD.

Annals of Neurology
|August 1, 1991
PubMed
Summary

Platelet-activating factor (PAF) plays a key role in brain injury and stroke. PAF receptor antagonists show promise for treating central nervous system disorders by improving recovery after ischemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting outcomes after acute reperfusion therapy for basilar artery occlusion.

European journal of neurology·2020
Same author

Thrombolysis and adjunct anticoagulation in patients with acute basilar artery occlusion.

European journal of neurology·2018
Same author

Ultra-acute diagnostics for stroke: Large-scale implementation of prehospital biomarker sampling.

Acta neurologica Scandinavica·2016
Same author

Symptomatic intracranial haemorrhage after thrombolysis with adjuvant anticoagulation in basilar artery occlusion.

European journal of neurology·2014
Same author

Effect of thyrotropin-releasing hormone on lipoxygenase-induced hypotension in the unanesthetized Guinea pig.

Pharmaceutical research·2013
Same author

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.

British journal of cancer·2011

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Platelet-activating factor (PAF) is an endogenous phospholipid with pro-inflammatory, hemostatic, and vasoactive properties.
  • PAF is synthesized in neurons and injured brain, released with other eicosanoids, and mediates effects via a specific receptor coupled to phospholipase C.
  • Cerebrovascular effects of PAF include blood-brain barrier disruption, edema, vasospasm, and direct neuronal toxicity.

Purpose of the Study:

  • To review the role of PAF as an endogenous mediator in cerebral disorders, particularly cerebral ischemia and trauma.
  • To discuss the mechanisms and significance of PAF-mediated effects in the central nervous system (CNS).
  • To explore the therapeutic potential of PAF receptor antagonists in CNS injury models.

Main Methods:

Related Experiment Videos

  • Review of experimental studies utilizing potent and selective PAF receptor antagonists.
  • Analysis of data from various experimental models of focal and global CNS ischemia and reperfusion injury.
  • Survey of biochemical, microvascular, functional, and behavioral outcomes in these models.

Main Results:

  • PAF receptor antagonists have demonstrated significant recovery in biochemical, microvascular, functional, and behavioral aspects in experimental models of CNS ischemia and trauma.
  • These findings underscore the role of PAF as a mediator in the pathology of stroke and neuroinjury.
  • Studies highlight the importance of phospholipid metabolism in stroke and neuroprotection.

Conclusions:

  • PAF is a significant mediator in CNS ischemia and reperfusion injury, contributing to stroke pathology.
  • PAF receptor antagonists represent a promising therapeutic strategy for treating cerebral disorders.
  • Further research into PAF-mediated effects and therapeutic interventions is warranted.